SCHEMBL7866980

SCHEMBL7866980

CC1=C(C(=O)N2CCOc3ccc(-c4ccc5nc(C)[nH]c5c4)cc3C2)SC(c2ncccn2)N1

nearest known ligand 0.59

Predicted protein targets (top 3)

geneUniProtsupporting neighboursconfidence
PIK3CA P42336 17/20 0.59
CREBBP Q92793 3/20 0.40
MTOR P42345 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3755458 0.81 PIK3CA (0.61) PIK3CACREBBPMTOR
SCHEMBL3753626 0.80 PIK3CA (0.79) PIK3CAMTOR
SCHEMBL3747280 0.79 PIK3CA (0.70) PIK3CACREBBPMTOR
SCHEMBL3750912 0.79 PIK3CA (0.63) PIK3CACREBBP
SCHEMBL3758971 0.79 PIK3CA (0.72) PIK3CACREBBP
SCHEMBL3754895 0.79 PIK3CA (0.63) PIK3CACREBBPMTOR
SCHEMBL3753487 0.78 PIK3CA (0.74) PIK3CAMTOR
SCHEMBL3752699 0.78 PIK3CA (0.67) PIK3CACREBBPMTOR
SCHEMBL2726184 0.78 PIK3CA (0.71) PIK3CACREBBP
SCHEMBL3756297 0.78 PIK3CA (0.62) PIK3CACREBBPMTOR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2010118208-A1 BENZOXAZEPIN-4- (5H) -YL DERIVATIVES AND THEIR USE TO TREAT CANCER EXELIXIS, INC. (US) 2010-10-14 WO disclosed